MediciNova, Inc. (MNOV) Covered Calls

You can sell covered calls on MediciNova, Inc. to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for MNOV (prices last updated Wed 4:16 PM ET):

MediciNova, Inc. (MNOV) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
1.36 +0.02 1.32 1.39 8K - 0.1
Covered Calls For MediciNova, Inc. (MNOV)
Expiration Strike Call Bid Net Debit Return
If Flat		 Annualized
Return If Flat
May 17 2.5 0.00 1.39 0.0% 0.0%
Jun 21 2.5 0.00 1.39 0.0% 0.0%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial

Extended Business Description

MediciNova, Inc., a biopharmaceutical company, focuses on acquiring and developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company's product candidate includes MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for the treatment of neurological disorders consisting of primary and secondary progressive multiple sclerosis; amyotrophic lateral sclerosis; and substance dependence and addiction. Its product pipeline also comprises MN-221 (bedoradrine), a selective -adrenergic receptor agonist for the treatment of acute exacerbations of asthma; MN-001 (tipelukast), an orally bioavailable small molecule compound to treat fibrotic diseases, including nonalcoholic steatohepatitis, idiopathic pulmonary fibrosis, and other fibrotic diseases; and MN-029 (denibulin), a tubulin binding agent to treat solid tumor cancers. The company was founded in 2000 and is headquartered in La Jolla, California.